Author:
Kawashiri Masa-aki,Sakata Kenji,Gamou Tadatsugu,Kanaya Honin,Miwa Kenji,Ueda Kosei,Higashikata Toshinori,Mizuno Sumio,Michishita Ichiro,Namura Masanobu,Nitta Yutaka,Katsuda Shoji,Okeie Kazuyasu,Hirase Hiroaki,Tada Hayato,Uchiyama Katsuharu,Konno Tetsuo,Hayashi Kenshi,Ino Hidekazu,Nagase Keisuke,Terashima Mitsuyasu,Yamagishi Masakazu
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference18 articles.
1. Kannel WB, McGee D, Gordon T (1976) A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 38:46–51
2. The multiple risk factor intervention trial (MRFIT) (1976) A national study of primary prevention of coronary heart disease. JAMA 235:825–827
3. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hirano T, Hibi K, Terashima M, Michishita I (2013) Impacts of age on coronary atherosclerosis and vascular response to statin therapy. Heart Vessels. doi: 10.1007/s00380-013-0387-1
4. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28
5. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets (TNT) Investigators (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352:1425–1435
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献